Wait Time from Suspicion to Surgery for Breast Cancer in Manitoba
- PMID: 27563506
- PMCID: PMC4985046
- DOI: 10.7759/cureus.680
Wait Time from Suspicion to Surgery for Breast Cancer in Manitoba
Abstract
Introduction: Breast cancer (BC) is the most common cancer in women. The pathway for its diagnosis and treatment is relatively standardized. Nevertheless, there can be significant delays affecting the journey. The aim of this retrospective study is to describe the BC wait times (WT) from suspicion to first surgery in Manitoba and to examine factors associated with WT variability.
Methods: The cohort is composed of patients with stages I-III breast cancer who were diagnosed between September 1, 2009, and August 31, 2010, and referred to a cancer center. Patients' journeys were tracked and divided into three sequential intervals from suspicion to first diagnostic test, from first diagnostic test to diagnosis and from diagnosis to first surgery.
Results: Four hundred and four patients were included of whom 134 presented through the screening program. There was no difference between the study cohort and population data from the provincial Cancer Registry concerning the distribution of age, stage of cancer or residence. The median WT from suspicion to surgery was 78 days. In the screen-detected group (SD), a difference in median WT from suspicion to first diagnostic test was found for distance. This finding was first to test location, where those who travel less had longer WT than those who have longer journeys. Patients who went to centers that offer both imaging and biopsy services, even if the required test is imaging only, had to wait longer than those who went to centers that provide imaging only. SD patients needing more than one diagnostic test had a longer WT from the first test to pathological diagnosis if the first test did not include a biopsy. Patients who were seen by surgeons before final pathological diagnosis had a shorter WT from diagnosis to first surgery than those who had the surgical consult after tissue diagnosis was made. A delay to surgery was observed in the whole cohort if a plastic surgeon is required in addition to the surgical oncologist and the non-screen detected group if a radiologist is necessary.
Conclusions: Variability in WT from suspicion to surgical management was found between various BC patient groups and between diagnostic centers with different types of services. The order of the provided diagnostic and surgical services may have contributed to WT. Addressing this variability by restructuring the care pathway and improving communication between different disciplines, has the potential to reduce WT.
Keywords: breast cancer wait suspicion surgery manitoba.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.Br J Cancer. 2017 May 9;116(10):1254-1263. doi: 10.1038/bjc.2017.87. Epub 2017 Mar 30. Br J Cancer. 2017. PMID: 28359079 Free PMC article.
-
Wait times for breast cancer surgery: effect of magnetic resonance imaging and preoperative investigations on the diagnostic pathway.J Oncol Pract. 2015 Mar;11(2):e131-8. doi: 10.1200/JOP.2014.002105. Epub 2015 Feb 10. J Oncol Pract. 2015. PMID: 25670200
-
Clinical and prognostic factors associated with diagnostic wait times by breast cancer detection method.Springerplus. 2014 Mar 6;3:125. doi: 10.1186/2193-1801-3-125. eCollection 2014. Springerplus. 2014. PMID: 24741470 Free PMC article.
-
A Patient-Centered Approach to Wait Times in the Surgical Management of Breast Cancer in the Province of Ontario.Ann Surg Oncol. 2015 Aug;22(8):2509-16. doi: 10.1245/s10434-014-4320-3. Epub 2015 Jan 7. Ann Surg Oncol. 2015. PMID: 25564166
-
Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.Dan Med J. 2012 Dec;59(12):B4568. Dan Med J. 2012. PMID: 23290296 Review.
Cited by
-
Reduced Time to Breast Cancer Diagnosis with Coordination of Radiological and Clinical Care.Cureus. 2017 Dec 7;9(12):e1919. doi: 10.7759/cureus.1919. Cureus. 2017. PMID: 29464133 Free PMC article.
-
Wait times for breast cancer surgery in lean and traditional care pathways: a multi-group path analysis.Can J Surg. 2025 May 21;68(3):E175-E181. doi: 10.1503/cjs.005524. Print 2025 May-Jun. Can J Surg. 2025. PMID: 40399035 Free PMC article.
-
Temporal Sequencing of Multimodal Treatment in Immediate Breast Reconstruction and Implications for Wait Times: A Regional Canadian Cross-Sectional Study.Plast Surg (Oakv). 2024 Nov;32(4):583-592. doi: 10.1177/22925503231152261. Epub 2023 Feb 7. Plast Surg (Oakv). 2024. PMID: 39430266
-
Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data.BMJ Open. 2022 Dec 15;12(12):e059669. doi: 10.1136/bmjopen-2021-059669. BMJ Open. 2022. PMID: 36521881 Free PMC article.
References
-
- Canadian Cancer Statistics, 2015, Special topic: Predictions of the future burden of cancer in Canada. [Feb;2016 ];Canadian Cancer Statistics, 2015 2015. http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20... Canada. 2015
-
- Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. Smith EC, Ziogas A, Anton-Culver H. JAMA Surg. 148:516–523. - PubMed
-
- Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Shin DW, Cho J, Kim SY, et al. Ann Surg Oncol. 2013;20:2468–2476. - PubMed
-
- Effect of interval to definitive breast surgery on clinical presentation and survival in early-stage invasive breast cancer. Vujovic O, Yu E, Cherian A, et al. Int J Radiat Oncol Biol Phys. 2009;75:771–774. - PubMed
-
- Influence of delay on survival in patients with breast cancer: a systematic review. Richards MA, Westcombe AM, Love SB, et al. http://www.ncbi.nlm.nih.gov/pubmed/10209974. Lancet. 1999;353:1119–1126. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources